Prandin approved as combination therapy with rosiglitazone or pioglitazone for type 2 diabetes Oct. 25, 2002
Antidiabetic, hypolipidemic and insulin-sensitizing properties described for novel thiazolidinedione Oct. 25, 2002
GSK and Biovitrum collaborate on 5-HT2C receptor agonists for obesity and other disorders Oct. 25, 2002
GlaxoSmithKline licenses Kissei's selective inhibitors of renal glucose transport for diabetes Oct. 25, 2002
RSS